ClinicalTrials.gov
public full text
Public Domain
Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
The objective of this study is to compare the efficacy and safety of aripiprazole as adjunctive therapy versus switching to different class of antidepressants for treating major depressive disorder partially or minimally responsive to ongoing antidepressant treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder#870503
- Rhythm and Depression#900959
- Naturalistic Adasuve Clinical Trial Study#980726
- VA Aripiprazole vs Esketamine for Treatment Resistant Depression#915960
- Escitalopram as a Mood Stabilizer for Bipolar II Disorder#800244
Record · ID 981439
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive